自拟青黛散治疗白塞氏综合征临床研究

Clinical research on treating Behcet's syndrome with Qingdai San

目的:评价青黛散治疗白塞氏综合征的有效性和安全性。方法:选择60例符合条件的白塞氏综合征患者,将其随机分为治疗组(30例)和对照组(30例),治疗组给予青黛散联合沙度利胺治疗,对照组只给予沙度利胺治疗。观察两组治疗前后临床症状疗效。结果:治疗组总有效率为96.67%,对照组总有效率为80.00%,两组之间疗效比较,差异有统计学意义(P<0.05)。结论:青黛散治疗白塞氏综合征临床疗效确切,值得临床推广应用。

Objective： To evaluate clinical effect and safety of Qingdai San on Behcet＇s syndrome. Methods： 60 patients were randomly divided into two groups, 30 cases for each. The control group was given sadow lee amine, another was given Qingdai San more. Clinical efficacy in two groups was recorded. Results： The total efficacy in the treatment was 96.67%, another was 80.00%. Clinical efficacy in two groups was compared, and the difference was statistically significant （P〈0.05）. Conclusion： The Qingdai San shows obvious effects on Behcet＇s syndrome, and was worthy of promotion.